Biologics Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Growth Rate of the Biologics Market Shape Industry Trends by 2034?
The biologics market has experienced rapid expansion in recent years. It is forecasted to grow from $533.36 billion in 2024 to $610.25 billion in 2025 at a CAGR of 14.4%. The historical growth drivers include an aging population, government initiatives, the ability to command high prices, and the increasing demand for immunology treatments.
The biologics market is projected to grow to $1,068.24 billion by 2029, with a CAGR of 15.0%. This growth is attributed to increased funding, technological advancements, improved healthcare access, robust R&D for oral biologics, a preference for pills over injections, and a strong pipeline of biologics. Key trends include leveraging revised regulations for new biologics development, a shift toward biologic drug development, R&D investments for innovative biologics, and research into biologics for complex disease treatment.
How Are the key drivers expanding the growth of the biologics Market?
The demand for personalized medicine is a key driver for the biologics market. Personalized medicine tailors treatments to individual patients based on their genetic and clinical profiles, transforming healthcare delivery. The FDA’s approval of 16 new personalized treatments for rare diseases in 2023 demonstrates the growing role of personalized medicine in healthcare and its impact on the biologics market.
Get Your Free Sample of the Global Biologics Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3606&type=smp
Who Are the Key Market Players Influencing the Growth of the Biologics Industry?
Major companies operating in the biologics market include:
• Merck & Co._x000D_
• Inc._x000D_
• AbbVie Inc._x000D_
• F. Hoffmann-La Roche AG_x000D_
• Johnson & Johnson_x000D_
What Key Market Trends Are Shaping the Future of the Biologics Industry?
Leading firms in the biologics sector are concentrating on creating cutting-edge products, such as oncology biosimilars, to reinforce their market position and gain a competitive edge. Oncology biosimilars are a category of biologic drugs utilized in cancer treatment. These are nearly identical versions of existing biologic medicines. For example, in May 2022, Biocon Biologics Limited, a subsidiary of Biocon Limited, an India-based biopharmaceutical firm, along with Viatris Inc., a US-based pharmaceutical company, introduced Abevmy, an oncology biosimilar, in Canada. Abevmy serves as a biosimilar treatment for cancer. Biosimilar medications are biological drugs that closely resemble other authorized biologics and are used for the same conditions with comparable safety and effectiveness.
Get Instant Access to the Global Biologics Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/biologics-global-market-report
What Are the Strategic Segments Comprising the Biologics Market and Their Growth Contributions?
The biologics market covered in this report is segmented –
1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By Drug Classification: Branded Drugs, Generic Drugs
3) By Route Of Administration: Oral, Other Route Of Administration
4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels
Subsegments:
1) By Monoclonal Antibodies (MAbs): Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Therapeutic Proteins: Hormones, Enzymes, Cytokines, Fusion Proteins
3) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines
Which Regions Are Emerging as Leaders in the Biologics Market?
North America was the largest region in the biologics market in 2024. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Defining Features of the Biologics Market?
Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials.
Browse Through More Similar Reports By The Business Research Company:
Therapeutic Proteins Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report
Oral Biologics & Biosimilars Global Market Report 2024
Orthobiologics Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
